The Times Online reports that a new company based in Boston, Foundation Medicine, has raised $25 million to develop a "one-stop-shop service for genomic diagnosis of cancer." The company's founders include Broad Institute director Eric Lander as well as Levi Garraway, Matthew Meyerson, and Todd Golub of the Dana Farber Cancer Institute and Harvard Medical School, the paper reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.